Det konstaterede dog også, at depotinjektioner ikke er velegnede til indledende behandling, da lægemidlet er mindst en uge om at formindske symptomerne, og patienterne kan have behov for hurtig kontrol over symptomerne.
However, it noted that prolonged-release injections are not suitable for use as initial treatment, because the medicine takes at least a week to reduce symptoms and patients may need rapid control of symptoms.